Endometrial Cancer Trial, Recruiting (NCT07044505)

Endometrial Cancer Trial, Recruiting NCT07044505 Sponsor: Stanford University Condition: Endometrial Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07044505 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometrial Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are scheduled to have gynecologic (female reproductive system) surgery at Stanford Healthcare
You still have your uterus and cervix intact
You have at least one fallopian tube and ovary on the same side that are still intact
You are 18 years of age or older
You are able to understand the study information and are willing to sign a written consent form

Who may not be able to join:

You have been diagnosed with cancer of the uterus lining or cervix, or pre-cancerous changes in those areas
You have previously had both fallopian tubes removed or have had a tubal ligation (tubes tied)
You are not able to give your own consent to participate
You tested positive for pregnancy before the surgery
You are currently having active uterine bleeding, such as your period
You currently have an IUD (intrauterine device) in place
You do not speak English and require an interpreter

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: James Ford, MD, Stanford University

Phone: (650) 724-9948

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07044505

Sponsor: Stanford University

Phase: Not Applicable

Status: Recruiting

Condition: Endometrial Cancer

Trial contact: (650) 724-9948

More information: https://clinicaltrials.gov/study/NCT07044505

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are scheduled to have gynecologic (female reproductive system) surgery at Stanford Healthcare
You still have your uterus and cervix intact
You have at least one fallopian tube and ovary on the same side that are still intact
You are 18 years of age or older
You are able to understand the study information and are willing to sign a written consent form

Who may not be able to join:

You have been diagnosed with cancer of the uterus lining or cervix, or pre-cancerous changes in those areas
You have previously had both fallopian tubes removed or have had a tubal ligation (tubes tied)
You are not able to give your own consent to participate
You tested positive for pregnancy before the surgery
You are currently having active uterine bleeding, such as your period
You currently have an IUD (intrauterine device) in place
You do not speak English and require an interpreter

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Stanford University

Registry

ClinicalTrials.gov

Start date

19 September 2025

Est. completion

1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Characterization of cellular composition in uterine lavage fluid

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov